Literature DB >> 19446449

The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes.

Bradley W Bolling1, Michael H Court, Jeffrey B Blumberg, C-Y Oliver Chen.   

Abstract

The dietary bioavailability of the isoflavone genistein is decreased in older rats compared to young adults. Since flavonoids are metabolized extensively by the UDP-glucuronosyltransferases (UGTs), we hypothesized that UGT flavonoid conjugating activity changes with age. The effect of age on flavonoid glucuronidation was determined using hepatic microsomes from male F344 rats. Kinetic models of UGT activity toward the flavonol quercetin and the isoflavone genistein were established using pooled hepatic microsomal fractions of rats at different ages, and glucuronidation rates were determined using individual samples. Intrinsic clearance (V(max)/K(m)) values in 4-, 18- and 28-month-old rats were 0.100, 0.078 and 0.087 ml/min/mg for quercetin-7-O-glucuronide; 0.138, 0.133 and 0.088 for quercetin-3'-O-glucuronide; and 0.075, 0.077 and 0.057 for quercetin-4'-O-glucuronide, respectively. While there were no differences in formation rates of total quercetin glucuronides in individual samples, the production of the primary metabolite, quercetin-7-O-glucuronide, at 30 microM quercetin concentration was increased from 3.4 and 3.1 nmol/min/mg at 4 and 18 months to 3.8 nmol/min/mg at 28 months, while quercetin-3'-O-glucuronide formation at 28 months declined by a similar degree (P<or=.05). At 30 and 300 microM quercetin concentration, the rate of quercetin-4'-O-glucuronide formation peaked at 18 months at 0.9 nmol/min/mg. Intrinsic clearance values of genistein 7-O-glucuronide increased with age, in contrast to quercetin glucuronidation. Thus, the capacity for flavonoid glucuronidation by rat liver microsomes is dependent on age, UGT isoenzymes and flavonoid structure. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446449      PMCID: PMC2872046          DOI: 10.1016/j.jnutbio.2009.02.006

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  32 in total

Review 1.  Aging biology and geriatric clinical pharmacology.

Authors:  Allan J McLean; David G Le Couteur
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

Review 2.  Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.

Authors:  Michael H Court
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 3.  Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants.

Authors:  Birgit Holst; Gary Williamson
Journal:  Curr Opin Biotechnol       Date:  2008-04-09       Impact factor: 9.740

4.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

5.  Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes.

Authors:  M H Court; D J Greenblatt
Journal:  Biochem Pharmacol       Date:  1997-04-04       Impact factor: 5.858

Review 6.  Effects of aging and caloric restriction on hepatic drug metabolizing enzymes in the Fischer 344 rat. II: Effects on conjugating enzymes.

Authors:  J A Leakey; H C Cunny; J Bazare; P J Webb; J C Lipscomb; W Slikker; R J Feuers; P H Duffy; R W Hart
Journal:  Mech Ageing Dev       Date:  1989-05       Impact factor: 5.432

7.  Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.

Authors:  Marelle G Boersma; Hester van der Woude; Jan Bogaards; Sjef Boeren; Jacques Vervoort; Nicole H P Cnubben; Marlou L P S van Iersel; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Chem Res Toxicol       Date:  2002-05       Impact factor: 3.739

Review 8.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.

Authors:  Claudine Manach; Gary Williamson; Christine Morand; Augustin Scalbert; Christian Rémésy
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

9.  Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9.

Authors:  Yakun Chen; Shenggu Xie; Shuqing Chen; Su Zeng
Journal:  Biochem Pharmacol       Date:  2008-05-15       Impact factor: 5.858

10.  Influence of age-related changes in rodent liver morphology and physiology on drug metabolism--a review.

Authors:  C F van Bezooijen
Journal:  Mech Ageing Dev       Date:  1984 Apr-May       Impact factor: 5.432

View more
  8 in total

Review 1.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

2.  Screening and identification of glyceollins and their metabolites by electrospray ionization tandem mass spectrometry with precursor ion scanning.

Authors:  Syeda S Quadri; Robert E Stratford; Stephen M Boué; Richard B Cole
Journal:  Anal Chem       Date:  2013-01-07       Impact factor: 6.986

3.  Bioavailability of phenolics from an oleuropein-rich olive (Olea europaea) leaf extract and its acute effect on plasma antioxidant status: comparison between pre- and postmenopausal women.

Authors:  R García-Villalba; M Larrosa; S Possemiers; F A Tomás-Barberán; J C Espín
Journal:  Eur J Nutr       Date:  2013-10-26       Impact factor: 5.614

4.  Microsomal quercetin glucuronidation in rat small intestine depends on age and segment.

Authors:  Bradley W Bolling; Michael H Court; Jeffrey B Blumberg; C-Y Oliver Chen
Journal:  Drug Metab Dispos       Date:  2011-05-04       Impact factor: 3.922

5.  Identification of glyceollin metabolites derived from conjugation with glutathione and glucuronic acid in male ZDSD rats by online liquid chromatography-electrospray ionization tandem mass spectrometry.

Authors:  Syeda S Quadri; Robert E Stratford; Stephen M Boué; Richard B Cole
Journal:  J Agric Food Chem       Date:  2014-03-11       Impact factor: 5.279

Review 6.  The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids.

Authors:  Aedín Cassidy; Anne-Marie Minihane
Journal:  Am J Clin Nutr       Date:  2016-11-23       Impact factor: 7.045

7.  Metabolic protection by the dietary flavonoid 7,8-dihydroxyflavone requires an intact gut microbiome.

Authors:  Priyanka Sharma; Camila Silva; Sarah Pfreundschuh; Hong Ye; Harini Sampath
Journal:  Front Nutr       Date:  2022-08-17

Review 8.  A Review of Factors Affecting Anthocyanin Bioavailability: Possible Implications for the Inter-Individual Variability.

Authors:  Merve Eda Eker; Kjersti Aaby; Irena Budic-Leto; Suzana Rimac Brnčić; Sedef Nehir El; Sibel Karakaya; Sebnem Simsek; Claudine Manach; Wieslaw Wiczkowski; Sonia de Pascual-Teresa
Journal:  Foods       Date:  2019-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.